Skip to main content
. Author manuscript; available in PMC: 2012 Sep 17.
Published in final edited form as: Immunity. 2011 Oct 20;35(4):633–646. doi: 10.1016/j.immuni.2011.08.016

Figure 1. Kinetics of the LCMV-Specific GP66–77 Stg and Polyclonal CD4+ T Cell Responses.

Figure 1

(A) Stg chimeric mice (top) or B6 mice (bottom) were infected with LCMV Armstrong, and 8, 15, 30, and 60 days p.i., splenocytes were analyzed for Thy1.1+ or GP66–77 tetramer+ CD4+ T cells.

(B and C) The number of GP66–77-specific CD4+ T cells in the spleen (B), inguinal lymph nodes, liver, lung, and bone marrow (C) was determined at various time points p.i.

Cumulative numbers of tetramer and Stg TCR transgenic cells from 9–7 mice/time point from more than 20 independent experiments are graphed + SD. See also Figure S1.